How to buy Eloxx Pharmaceuticals stock (ELOX)

Eloxx Pharmaceuticals is a biotechnology business based in the US. Eloxx Pharmaceuticals shares (ELOX) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Eloxx Pharmaceuticals employs 18 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Eloxx Pharmaceuticals stock

Buy Eloxx Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Eloxx Pharmaceuticals stock price (PINK: ELOX)

Use our graph to track the performance of ELOX stocks over time.

Eloxx Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$0.00
52-week range	$0.00 - $1.74
50-day moving average more info button	$0.00
200-day moving average more info button	$0.51
Wall St. target price	$30.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-8.88

Eloxx Pharmaceuticals price performance over time

Historical closes compared with the close of $0 from 2024-12-20

1 week (2024-12-13)	0
1 month (2024-11-22)	-100.00%
3 months (2024-09-19)	0
6 months (2024-06-21)	-100.00%

1 year (2023-12-22)	-100.00%
2 years (2022-12-22)	-100.00%
3 years (2021-12-22)	29.6
5 years (2019-12-20)	288.8

Eloxx Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-73.24%
Return on equity TTM	-615.23%
Profit margin	0%
Book value	$-6.53
Market Capitalization more info button	$314

TTM: trailing 12 months

Eloxx Pharmaceuticals share dividends

We're not expecting Eloxx Pharmaceuticals to pay a dividend over the next 12 months.

Have Eloxx Pharmaceuticals's shares ever split?

Eloxx Pharmaceuticals's shares were split on a 1:40 basis on 1 December 2022 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eloxx Pharmaceuticals shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Eloxx Pharmaceuticals shares which in turn could have impacted Eloxx Pharmaceuticals's share price.

Eloxx Pharmaceuticals share price volatility

Over the last 12 months, Eloxx Pharmaceuticals's shares have ranged in value from as little as $0 up to $1.74. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Eloxx Pharmaceuticals's is -24.601. This would suggest that Eloxx Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Eloxx Pharmaceuticals has bucked the trend.

Eloxx Pharmaceuticals overview

Eloxx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts. .

Frequently asked questions

null
What percentage of Eloxx Pharmaceuticals is owned by insiders or institutions?
Currently 5.981% of Eloxx Pharmaceuticals shares are held by insiders and 19.586% by institutions. How many people work for Eloxx Pharmaceuticals?
Latest data suggests 18 work at Eloxx Pharmaceuticals. When does the fiscal year end for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals's fiscal year ends in December. Where is Eloxx Pharmaceuticals based?
Eloxx Pharmaceuticals's address is: 480 Arsenal Way, Watertown, MA, United States, 02472 What is Eloxx Pharmaceuticals's ISIN number?
Eloxx Pharmaceuticals's international securities identification number is: US29014R1032 What is Eloxx Pharmaceuticals's CUSIP number?
Eloxx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 817208408